Gabapentin in horses: Validation of an analytical method for gabapentin quantitation

Journal of Analytical Toxicology

Volumn 31, Issue 9, 2007, Pages 555-565

  Lehner, A F ^a   Stewart, J ^a   Dafalla, A ^b   Ely, K J ^b   Connerly, A L ^b   Jones, C N ^b   Elkholy, H ^b   Thompson, K ^b   Tobin, T ^a   Dirikolu, L ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b TUSKEGEE UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; GABAPENTIN; LACTAM; TRIMETHYLSILYL DERIVATIVE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; BODY FLUID; CONTROLLED STUDY; DRUG STRUCTURE; ELECTROSPRAY; GAS CHROMATOGRAPHY; HORSE; MASS SPECTROMETRY; NONHUMAN; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION;

EQUIDAE;

EID: 37349085247     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/31.9.555     Document Type: Article

References (26)

1. Association of Racing Commissioners International. Uniform Classification Guidelines for Foreign Substances and Recommended Penalties and Model Rule. Lexington, KY, 1998.
2. AORC. Minimum criteria for identification by chromatography and mass spectrometry. Association of Official Racing Chemist Proposed Guidelines, Lexington, KY, 2001.
3. D.M. Boothe. Anticonvulsant therapy in small animals. Veterinary Clinical Practice of North America: Small Animal Practice 28: 410-448 (1998).
4. D. Chadwick. Drug profile: gabapentin. Lancet 343: 89-91 (1994).
5. L. Dirikolu, A. Dafalla, K.J. Ely, A.L. Connerly, C.N. Jones, H. ElkHoly, A.F. Lehner, K. Thompson, and T. Tobin. Gabapentin in horses: pharmacokinetics and clinical pharmacology. Journal of Veterinary Pharmacology and Therapeutics, in press.
6. N.B. Finnerup, H. Gottrup, and T.S. Jensen. Anticonvulsants in central pain. Expert Opinion on Pharmacotheraphy 3: 1411-1420 (2002).
7. C. Gambelunghe, G. Mariucci, M. Tantucci, and M.V. Ambrosini. Gas chromatography-tandem mass spectrometry analysis of gabapentin in serum. Biomed Chromatogr. 19: 63-67 (2005).
8. D. Gauthiera and R. Gupta. Determination of gabapentin in plasma by liquid chromatography with fluorescence detection after solid-phase extraction with a C18 column. Clin. Chem. 48: 2259-2261 (2002).
9. K.L. Goa and E.M. Sorkin. Gabapentin, a review of its pharmacological properties and clinical potential in epilepsy. Drugs 46: 409-427 (1993).
10. H. Hengy and E.U. Kölle. Determination of gabapentin in plasma and urine by high-performance liquid chromatography and precolumn labeling for ultraviolet detection. J. Chromatogr. B 341: 473-478 (1985).
11. W.D. Hooper, M.C. Kavanagh, and R.G. Dickinson. Determination of gabapentin in plasma and urine by capillary column gas chromatography. J. Chromatogr. B 529: 167-174 (1990).
12. D.R. Ifa, M. Falci, M.E. Moraes, F.A.F. Bezerra, M.O. Moraes, and G. de Nucci. Gabapentin quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry. Application to bioequivalence study. J. Mass Spectrom. 36: 188-194 (2001).
13. R. Knorle, T.J. Feuerstein, and A. Schulze-Bonhage. Determination of gabapentin-lactam in serum of patients under gabapentin therapy. Arzneimittelforschung 54: 139-142 (2004).
14. M.M. Kushnir, J. Crossett, P.I. Brown, and F.M. Urry. Analysis of gabapentin in serum and plasma by solid-phase extraction and gas chromatography-mass spectrometry for therapeutic drug monitoring. J. Anal. Toxicol. 23: 1-6 (1999).
15. W.A. Lagreze, R. Muller-Velten, and T.J. Feuerstein. The neuroprotective properties of gabapentin-lactam. Graefes Arch Clin Exp Ophthalmol 239: 845-849 (2001).
16. K.M. Matar and M.E. Abdel-Hamid. Rapid tandem mass spectrometric method for determination of gabapentin in human plasma. Chromatographia 61: 499-504 (2005).
17. F.W. McLafferty and F. Turecek. Interpretation of Mass Spectra, 4th Ed. University Science Books, Sausalito, CA, 1993.
18. A.E. Pierce. Silylation of Organic Compounds. Pierce Chemical Co., Rockford, IL, 1982.
19. H. Potschka, T.J. Feuerstein, and W. Loscher. Gabapentin-lactam, a close analogue of the anticonvulsant gabapentin, exerts convulsant activity in amygdala kindled rats. Naunyn Schmiedebergs Arch Pharmacol. 361: 200-205 (2000).
20. R.R. Rando and F.W. Bangerter. The irreversible inhibition of mouse brain gamma-aminobutyric acid (GABA)-alpha-ketoglutaric acid transaminase by gabaculine. J. Amer. Chem. Soc. 98: 6762-6764 (1976).
21. H. Rosner, L. Rubin, and A. Kestenbaum. Gabapentin adjunctive therapy in neuropathic pain states. Clinical Journal of Pain 12: 56-58 (1996).
22. C. Taylor. Emerging perspectives on the mechanism of action of gabapentin. Neurology 44: S10-16 (1994).
23. +2 influx and synaptic transmission in rat hippocampus and neocortex. Eur. J. Pharmacol. 449: 221-228 (2003).
24. F. Van Lente and V. Gatautis. Cost-efficient use of gas chromatography-mass spectrometry: a "piggyback" method for analysis of gabapentin. Clin. Chem. 44: 2044-2045 (1998)
25. C.E. Wolf II, J.J. Saady, and A. Poklis. Determination of gabapentin in serum using solid-phase extraction and gas-liquid chromatography. J. Anal. Toxicol. 20: 498-501 (1996).
26. B. Zucker, D.E. Ludin, T.A. Gerds, C.H. Lucking, G.B. Landwehrmeyer, and T.J. Feuerstein. Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington's disease. Naunyn Schmiedebergs Arch Pharmacol. 370: 131-139 (2004).